MedPath

Hesperidin

Generic Name
Hesperidin
Drug Type
Small Molecule
Chemical Formula
C28H34O15
CAS Number
520-26-3
Unique Ingredient Identifier
E750O06Y6O

Overview

Hesperidin is a flavan-on glycoside found in citrus fruits.

Indication

No indication information available.

Associated Conditions

  • Capillary fragility
  • Venous Insufficiency
  • Vessels; Varicose

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
RUVENTIN FILM COATED TABLET 500MG
SIN16068P
TABLET, FILM COATED
50mg
12/29/2020
DIOSPER FILM COATED TABLET
SIN11942P
TABLET, FILM COATED
50 mg
5/21/2002
DAFLON TABLET 500 mg
SIN01067P
TABLET, SUGAR COATED
50 mg
5/12/1988
DAVMORID FILM COATED TABLET
SIN16960P
TABLET, FILM COATED
50mg
2/20/2024
DAFLON FILM-COATED TABLET 1000 mg
SIN15669P
TABLET, FILM COATED
100 mg
4/16/2019
VESSOSMIN FILM COATED TABLET 500MG
SIN17191P
TABLET, FILM COATED
50mg
3/4/2025

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
DAFLON TABLETS 1000MG
N/A
servier hong kong limited
N/A
N/A
4/26/2023
DIOFLEX TAB
N/A
N/A
N/A
6/17/2004

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
ROSE HIPS 250 PLUS NU LIFE
nu-life nutrition ltd.
00064696
Tablet - Oral
50 MG
12/31/1963
SPECIAL C
anabolic laboratories inc.
00046647
Capsule - Oral
32.5 MG / CAP
12/31/1963
ROSE HIPS 500PLUS NU LIFE
nu-life nutrition ltd.
00345431
Tablet - Oral
100 MG
12/31/1972
CILOBANA CPA TAB
anabolic laboratories inc.
00046671
Tablet - Oral
75 MG / TAB
12/31/1968

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
DAFLON 500mg comprimidos recubiertos
4691-2004
COMPRIMIDO RECUBIERTO
Medicamento Sujeto A Prescripción Médica
Not Commercialized
DAFLON 500mg comprimidos recubiertos.
4691-2004IP
COMPRIMIDO RECUBIERTO
Sin Receta
Not Commercialized
DAFLON 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Servier Austria Gmbh
1-20685
COMPRIMIDO RECUBIERTO CON PELÍCULA
Sin Receta
Commercialized
DAFLON 500mg comprimidos recubiertos
4691-2004IP1
COMPRIMIDO RECUBIERTO
Sin Receta
Commercialized
VENORUTON DIOSMINA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Laboratorio Stada S.L.
77434
COMPRIMIDO RECUBIERTO CON PELÍCULA
Sin Receta
Commercialized
DIOSMINA KERN PHARMA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
75652
COMPRIMIDO RECUBIERTO CON PELÍCULA
Sin Receta
Commercialized
DAFLON 500 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA
Laboratorios Servier S.L.
59080
COMPRIMIDO RECUBIERTO
Sin Receta
Commercialized
Daflon 500mg comprimidos recubiertos
4691-2004IP3
COMPRIMIDO RECUBIERTO
Medicamento Sujeto A Prescripción Médica
Not Commercialized
DAFLON 500 mg COMPRIMIDOS RECUBIERTOS
Servier Austria Gmbh
1-20685IP
COMPRIMIDO RECUBIERTO
Sin Receta
Commercialized
DAFLON 500mg comprimidos recubiertos
4691-2004IP2
COMPRIMIDO RECUBIERTO
Medicamento Sujeto A Prescripción Médica
Not Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.